176 results on '"Karikios, Deme"'
Search Results
2. Oncology and intensive care doctors' perception of intensive care admission of cancer patients: A cross-sectional national survey
3. Challenges and solutions to cancer-related financial toxicity according to Australian health professionals: qualitative results from a national survey
4. Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study
5. Economic impact of using risk models for eligibility selection to the International lung screening Trial
6. Predicting the likelihood of elevated transaminases in lung cancer patients undergoing immune checkpoint blockade.
7. Large-Scale Population-Based Surveys Linked to Administrative Health Databases as a Source of Data on Health Utilities in Australia.
8. Health utilities for participants in a population-based sample who meet eligibility criteria for lung cancer screening
9. Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods
10. Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer
11. Variations in Patterns of Prescribing Durvalumab in Stage III Lung Cancer: A Survey of Australian Medical Oncologists.
12. Out‐of‐pocket health care expenses for people with and without cancer, New South Wales, 2020: a cross‐sectional study.
13. Evaluating Systemic Burnout in Medical Oncology Through a National Oncology Mentorship Program
14. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
15. Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines
16. Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians
17. Treatment patterns and long‐term survival outcomes for patients with stage III non‐small cell lung cancer: A retrospective study.
18. Common Sense Oncology: outcomes that matter
19. Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study
20. A protocol for modelled evaluations to maximise the long-term health and economic gains of lung cancer interventions in Australia: The Lung cancer Evaluation And Policy program (LEAPp)
21. Discussing and prescribing expensive unfunded anticancer drugs in Australia
22. Improving Access to Cancer Clinical Trials for Patients From Culturally and Linguistically Diverse Backgrounds in Australia: A Survey of Clinical and Research Professionals.
23. Case series: Immune checkpoint inhibitor-induced transverse myelitis
24. Treatment patterns and long‐term survival outcomes for patients with stage III non‐small cell lung cancer: A retrospective study
25. Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers
26. Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT
27. Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia
28. CONSENT - A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent to Improve Patient Understanding of Early Phase Oncology Clinical Trials – GBM Cohort (Nonrandomised) Analysis
29. How accurate are medical oncologists’ impressions of management of metastatic colorectal cancer in Australia?
30. Immunotherapy‐induced sarcoidosis in patients with melanoma treated with PD‐1 checkpoint inhibitors: Case series and immunophenotypic analysis
31. SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response
32. Opinions and strategies of Australian health professionals on tackling cancer‐related financial toxicity: A nationwide survey
33. Evaluating Prognostic Factors for Sex Differences in Lung Cancer Survival: Findings From a Large Australian Cohort
34. Australian Cancer Physicians and the Pharmaceutical Industry: A Survey of Attitudes and Interactions
35. Nurse-led supportive care management: A 6-month review of the role of a nurse practitioner in a chemotherapy unit
36. Opinions and strategies of Australian health professionals on tackling cancer‐related financial toxicity: A nationwide survey.
37. Synchronous Recurrence of Metachronous Lung Cancer and Hodgkin Lymphoma Within an Axillary Lymph Node Isolated on 18F-FDG PET/CT
38. Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT)
39. Metabolic information on staging FDG-PET–CT as a prognostic tool in the evaluation of 97 patients with gastric cancer
40. Lung cancer treatment patterns and factors relating to systemic therapy use in Australia.
41. Lung cancer treatment patterns and factors relating to systemic therapy use in Australia
42. Medical Oncology Group of Australia position statement: COVID ‐19 vaccination in patients with solid tumours
43. Additional file 1 of Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines
44. Immunotherapy in advanced Merkel cell carcinoma: Sydney west cancer network experience
45. Discussing the Costs and Financial Burden of Cancer and its Treatment: A Systematic Review of Clinical Guidelines
46. Retrospective Evaluation of the Use of Pembrolizumab in Malignant Mesothelioma in a Real-World Australian Population
47. Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic
48. Activin as a biomarker for platinum resistance in non-small cell lung cancer.
49. Final Results of the Dream Trial: A Phase 2 Trial of Durvalumab with First-Line Chemotherapy in Mesothelioma with a Safety Run-In
50. ADJUVANT LIPIODOL I-131 IN RESECTED HEPATOCELLULAR CARCINOMA: A RETROSPECTIVE REVIEW OF 22 PATIENTS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.